Oct 26 (Reuters) – The US health regulator has accepted Merck’s experimental targeted drug for a priority review based on data from a late-stage trial where it extended survival in women with an advanced form of endometrial cancer. The drug, sacituzumab tirumotecan, also known as sac-TMT, delivers a
By Bhanvi Satija and Sneha S K MADRID, Oct 26 (Reuters) – An experimental drug for a hard-to-treat bone cancer, being developed by Hansoh Pharmaceutical and GSK, helped patients live longer without the disease worsening, according to data presented by researchers at a medical meeting on Monday. Pati
NAIROBI, Oct 26 (Reuters) – Kenya on Monday released from quarantine the first group of people who came into contact with its index Ebola patient, a milestone in its efforts to contain cases to a single infection cluster. The 20 people released completed 21 days of monitoring without developing Ebol
After Fighting in Gaza and Battling PTSD, Shahar Varon Seeks a Voice In Israel’s Mental Health Future Varon said any future government, regardless of who serves as prime minister, must pass a mental health law that establishes a dedicated, structured budget for mental healthcare By Maayan Hoffman /
(Austell, GA) — Six Flags will be adding seat belts to some of its rollercoasters after a man fell to his death on the Goliath ride in Georgia earlier this month. The company announced the move in a letter to customers on Friday as it steps up safety measures across its parks. The amusement park cha
By Christy Santhosh Oct 26 (Reuters) – Surgery Partners said on Monday it would be taken private by HealthSpan Partners, an affiliate of nonprofit hospital system Bon Secours Mercy Health, in a deal valued at about $5.7 billion including debt, sending its shares up 46%. Private equity group Bain Cap
Oct 26 (Reuters) – Regeneron said on Monday it extended its agreement with a US health authority to provide additional supply of its Ebola treatment, amid a growing outbreak in Africa. Here are some details: • The new agreement with the US Biomedical Advanced Research and Development Authority, expa
SAO PAULO, Oct 26 (Reuters) – Brazil has identified a second Newcastle disease outbreak in Santa Catarina state at a poultry farm in Coronel Freitas, the Agriculture Ministry said late on Sunday. The new case lies within an existing restricted area, requiring only a small adjustment to the containme
LONDON, Oct 26 (Reuters) – Senior hospital doctors in England are set to stage a two-day strike in November, the British Medical Association said on Monday, following a government recommendation of a below-inflation pay rise. The strike, due to take place on November 25 and 26, is the latest example
Oct 26 (Reuters) – Obesity drug developer Corxel Pharmaceuticals will go public in the US through a merger with special purpose acquisition company Amanat Acquisition Corp, the companies announced on Monday. • The success of newer weight-loss therapies has spurred a wave of investments by biotechs l
BEIJING, Oct 26 (Reuters) – China’s drug regulator said on Monday it approved the blood thinner asundexian from Bayer, a potential boost for the German drugmaker in the world’s second-largest pharmaceutical market as it moves to counter competition from generic medicines. Bayer is betting on asunde
Oct 26 (Reuters) – Indian drugmaker Mankind Pharma reported an over 39% jump in second-quarter profit on Monday, helped by strong demand for chronic therapies such as diabetes and cardiac treatments, Here are the details: • Consolidated net profit rose to 7.11 billion rupees ($74.7 million) for the
By Jennifer Rigby LONDON, Oct 26 (Reuters) – A team of leading Ebola scientists will travel to Nigeria to help investigate how the country’s first patient in more than a decade got infected, Africa CDC Director-General Jean Kaseya said. Their task will involve trying to work out how the female patie
By Elias Biryabarema KAMPALA, Oct 25 (Reuters) – Ugandan citizens returning to the country with a history of travel to Democratic Republic of Congo will be quarantined for 21 days, Health Minister Chris Baryomunsi said on Sunday as Uganda tightened Ebola precautions. Uganda says it is Ebola-free aft
Oct 25 (Reuters) – US based not-for-profit health system Bon Secours Mercy Health is in late-stage talks to buy a majority stake in Surgery Partners in a deal which would value the company at roughly $6 billion including debt, the Financial Times reported on Sunday. Here are a few details: • The pot
By Bhanvi Satija MADRID, Oct 25 (Reuters) – Takeda Pharmaceutical plans to seek regulatory approval in Japan next year for its gastric cancer drug, after it extended overall survival and delayed disease progression in a late-stage study, a company executive told Reuters. The drug, arcotatug tavateca
By Bhanvi Satija MADRID, Oct 25 (Reuters) – AstraZeneca’s experimental drug sone-ve helped patients with advanced stomach cancer who had received at least two prior treatments to live longer than analysts had expected, according to late-stage trial data presented on Sunday. Patients on the drug live
By Elias Biryabarema KAMPALA, Oct 25 (Reuters) – Ugandan citizens returning to the country with a history of travel to Democratic Republic of Congo will be quarantined for 21 days, Health Minister Chris Baryomunsi said on Sunday as Uganda tightened Ebola precautions. Uganda says it is Ebola-free aft
(Corrects first bullet point showing median survival for trial patients as 21.1 months vs. 12.7 months, not 21.7 months vs 12.1 months) By Deena Beasley Oct 24 (Reuters) – Amgen’s Imdelltra used in combination with AstraZeneca’s immunotherapy Imfinzi reduced the risk of death by 58% compared to the
Oct 24 (Reuters) – Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumors to disappear or shrink in an early-stage trial. J&J had gained access to the drug through its $3.05 billion deal to buy Halda Therapeutics last year. Here are more details: • The
By Camillus Eboh and George Obulutsa ABUJA, Oct 23 (Reuters) – Genomic analysis of Nigeria’s only confirmed Ebola case shows the virus is closely related to the strain detected in Kenya’s index case, Nigeria’s health minister Muhammad Ali Pate said on Friday, offering the first genetic link between
Oct 23 (Reuters) – Windward Bio filed for a US initial public offering on Friday, becoming the latest drug developer seeking to capitalize on renewed investor interest in biotech listings. Biotech has been one of the more active sectors in this year’s fall IPO market, even as rising bond yields and
By Caroline Humer NASHVILLE, Oct 23 (Reuters) – CVS Health Chief Medical Officer Dr. Amy Compton-Phillips on Friday said healthcare affordability and access could potentially improve if pharmacists in its 9,000 retail stores play a bigger role in chronic disease management, helping consumers stay on
By Caroline Humer NASHVILLE, Oct 23 (Reuters) – Billionaire entrepreneur Mark Cuban said on Friday that he is “not a doomer” about artificial intelligence and that companies should be able to use the technology to protect themselves from AI-driven hacks by agents that he compared to cockroaches. “It
By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, Oct 23 (Reuters) – Swiss drugmaker Novartis’ oral multiple sclerosis (MS) drug remibrutinib meaningfully reduced relapses in patients, according to data presented at a medical conference in Toronto on Friday, but less than analysts had expected.
By Sriparna Roy Oct 23 (Reuters) – Bristol Myers Squibb on Friday disclosed a patient death in an early-stage trial studying its experimental CAR-T cell therapy in patients with relapsing or progressive forms of multiple sclerosis. The death, which the company said occurred after the study was pause
(SRN NEWS) – Michigan Democrat Abdul El-Sayed says his Medicare for All proposal would make the government the primary insurer for everyone, while private companies could still offer supplemental coverage. In a recent interview, El-Sayed described the government as the sole buyer of health care. He
BEIJING, Oct 23 (Reuters) – China should offer more support to families to stabilise the number of new births, the cabinet said on Friday, as policymakers seek to address the country’s population decline and record-low birth rate. The government should refine policies including those related to marr
Oct 23 (Reuters) – Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer’s disease and other neurological disorders. Pathos AI also raised $237 million in a Series E funding roun
Oct 23 (Reuters) – Indian drugmaker Dr Reddy’s Laboratories reported a better-than-expected quarterly profit on Friday, as domestic demand helped cushion the slowdown in its key US market. Consolidated net profit after tax fell to 9.25 billion rupees ($97.43 million) in the quarter ended September 3
